fashion -WSS

fashion

author：comprehensive 2025-09-29 22:47:06 - browse：7631

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout LOUD podcast: Live from STAT Breakthrough Summit West

WSS

The unintended consequences of overturning Roe v. Wade

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Cytokinetics CEO stresses company can launch heart drug on its own

Criminal prosecution for violating HIPAA: an emerging threat

Chamber of Commerce, DOJ clash in court over drug prices

Senate bill would ban some hospital facility fees

entertainment

fashion

leisure time

At least 13 dead in Texas as scorching temps continue

Big Tobacco's 'harm reduction': Is it for real, or a sham?

How one medical school became remarkably diverse

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Affirmative action in medical school literally saved lives

Midwives could help bridge maternal health disparities in the U.S.

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Helping hospitals and community health centers plan for resilience

Anesthesiologist group: stop taking Ozempic before surgery

Arc Institute generative AI designs new CRISPR systems

leisure time

Why the quest to eradicate polio has stumbled

Neurocrine congenital adrenal hyperplasia trial succeeds

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Free Covid tests will again be offered to all U.S. households

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Anxious about a speech? A startup wants you to pop a minty cardiac drug

focus

hotspot

hotspot

knowledge